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Abstract: Cigarette smoking has been strongly associated with abdominal aortic aneurysm 
(AAA), but the components of tobacco smoke involved in AAA have not been identiﬁ  ed. 
Benzo(a)pyrene (BaP) is an important constituent in cigarette smoke capable of induction 
of alterations strikingly similar to the pathological changes seen during AAA development. 
We therefore hypothesized that BaP exposure contributes to the development of AAA. In this 
study, C57/B6J mice were treated with vehicle, angiotensin II (AngII) (0.72 mg/kg/day), BaP 
(10 mg/kg/week), or the combination of AngII and BaP, for 5 weeks, and then examined for 
incidence of AAA and pathological changes of the aortic wall. Results showed that incidence 
of AAA formation in C57/B6J mice treated with BaP and AngII was signiﬁ  cantly higher than 
that in AngII-treated mice (7 of 12 compared to 2 of 12). Further, ﬁ  ve mice in the group treated 
with AngII/BaP and one in the group treated with AngII exhibited AAA rupture and hematoma. 
BaP caused macrophage inﬁ  ltration, disarray of elastic lamella, and loss of vascular smooth 
muscle cells (VSMCs). We conclude that BaP aggravates AAA formation and rupture in C57/
B6J mice by promoting macrophage inﬁ  ltration, degeneration of elastic lamella, and loss of 
VSMCs in the aortic wall.
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Introduction
Abdominal aortic aneurysm (AAA) becomes increasingly common among the elderly 
(Bengtsson et al 1996; CDCP 2002). Rupture of AAA, a deadly complication of the 
disease, accounts for 15,000 deaths every year in the US (Kochanek and Smith 2004), 
and is ranked as the 13th most common cause of death in the US (Patel et al 1995). Lack 
of therapeutic drugs for the treatment of AAA is largely due to a poor understanding 
of the pathological mechanisms of this disease, a fact that justiﬁ  es the urgent need for 
basic and clinical research on this disease.
Benzo(a)pyrene (BaP), a byproduct of combustion of tobacco, is an important 
component of cigarette smoke (Schmeltz et al 1974, 1975), and cigarette smoking has 
been strongly associated with AAA development (Wilmink et al 1999; Jamrozik et al 
2000; Vardulaki et al 2000; Wanhainen et al 2005) and rupture (Chang et al 1997). 
Compared to nonsmokers, current smokers are, on average, about 8× more likely to have 
an AAA (Wilmink et al 1999; Jamrozik et al 2000; Vardulaki et al 2000; Wanhainen 
et al 2005), and ex-smokers are 4 × more likely to succumb to this disease (Wilmink 
et al 1999; Jamrozik et al 2000). This suggests that one or more of the components 
present in cigarette smoke causes or aggravates AAA.
It has been estimated that the average intake of BaP is about 700 ng/day for unﬁ  l-
tered cigarettes or 400 ng/day for ﬁ  ltered cigarettes in smokers who consume a pack of 
cigarettes per day (NAS 1972). The exposure of smokers (a pack of cigarette per day) 
to similar compounds polycyclic aromatic hydrocarbons has been estimated to be 6 to 
10 μg/day (ATSDR 1995). As an important component of cigarette smoke, BaP trig-Vascular Health and Risk Management 2008:4(5) 1096
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gers a variety of biological responses, such as inﬁ  ltration of 
macrophage and related inﬂ  ammatory reactions (Curfs et al 
2004; Lecureur et al 2005), up-regulation of metalloprotein-
ase (MMP) expression (Haque et al 2005), and activation of 
nuclear factor-κB (Pei et al 2002; Weng et al 2004). Impor-
tantly, all of these pathological changes are also observed in 
the process of AAA development. We therefore hypothesized 
that BaP exposure contributes to AAA formation.
Often used in AAA animal models, angiotensin II (AngII) 
induces AAA in apoE-deﬁ  cient mice with incidence rates of 
about 90% (Daugherty et al 2000; Deng et al 2003; Martin-
McNulty et al 2003), and in C57/BL6J mice with much lower 
incidence rates but the same pathological changes within 
the aortic wall (Deng et al 2003). Considering that the high 
incidence rate of AAA in AngII-treated apoE-deﬁ  cient mice 
leaves little room to examine the putative effects of BaP on 
the development of AAA, in the present study we elected to 
examine AAA in C57/B6J mice given AngII-infusion.
Experimental methodology
Animals and treatment of AngII and BaP
C57/B6J mice (6 to 8 months old male) were purchased from 
The Jackson Laboratory (Bar Harbor, ME, USA) and housed 
in according to National Institutes of Health (NIH) guidelines 
for animal care and use. A subpressor dose (0.72 mg/kg/day) of 
AngII (Sigma, St. Louis, MO, USA) or an equivalent volume 
of saline was administered using an osmotic pump (Model# 
2004; Alzet, Cupertino, CA, USA), as described below. After 
calculating the desired concentration and preparing AngII 
solution, the pumps were ﬁ  lled with AngII saline solution and 
incubated in a 37 °C water bath for 12 hours. Animals were 
anesthetized and skin in the mid-scapular area shaved and steril-
ized. A mid-scapular incision was made, and a pocket for the 
pump was created under the subcutaneous tissue. After inserting 
the pump into the pocket, the wound was closed with clips. BaP 
(Sigma) was dissolved in medium chain triglyceride oil (Mead 
Johnson Nutritional, Evansville, IN, USA) at a concentration 
of 2 mg/ml. Mice were injected intraperitoneally with BaP at a 
dose of 10 mg/kg body weight or equivalent volume of oil once 
a week for 5 weeks. Current guidelines for use of biohazardous 
materials were followed when using BaP.
Harvesting and evaluation of aortas
Following individual or combined treatments, the animals were 
sacriﬁ  ced with CO2; and aortas were harvested and cleaned 
under a dissection microscope. The suprarenal segments of 
aortas (a length of 1 cm above the left renal artery) were imbed-
ded in Tissue-Tek O.C.T. (Sakura Finetek Inc., Torrance, CA, 
USA) embedding medium and frozen in liquid nitrogen. Five 
micrometer serial sections of the suprarenal aorta segments 
were prepared and stained with hematoxylin-eosin (HE) stain. 
Because of irregular shapes of the aortic rings, we measured the 
circumference, instead of diameter, of the rings for comparison 
among the experiment groups. The circumference (following 
the endothelial layer) of the aorta was measured with the aid 
of NIH Image J. The aortas with circumference increases equal 
to or greater than 50% of the average circumference (946 ± 69 
micrometer) of the control mice were considered aneurysm 
formation. The difference in the incidences of AAA between 
AngII-treated mice and the mice treated with both AngII and 
BaP was examined by Fisher’s Exact Test.
Histological examination
For parafﬁ  n-imbedding, animals were perfused through 
the left ventricle sequentially with 0.9% sodium chloride 
and with 10% paraformaldehyde solution. The aorta was 
removed and preserved in 10% paraformaldehyde before 
processing for embedding. For frozen sections, each aorta 
was embedded in Tissue-Tek O.C.T. embedding medium and 
frozen in liquid nitrogen. Five micrometer serial sections of 
suprarenal aorta segments were prepared and stained with HE 
stain or elastic Van Gilson stain for histological evaluation 
of vascular structures.
Identiﬁ  cation of macrophages in the 
aortic wall by immunohistochemistry 
staining
The serial frozen sections of the arteries were examined for 
macrophage inﬁ  ltration using immunohistochemistry stain 
with the monoclonal F4/80 antibody against mouse macro-
phage (GeneTex, Inc. Cat# GTX26640). The slides were 
thawed at room temperature for 20 minutes, and ﬁ  xed with 
acetone for 10 minutes. After 30 minutes of treatment in the 
blocking solution (1% gelatin in phosphate buffer solution 
[PBS]) at room temperature, tissue sections were incubated 
at room temperature with the diluted primary antibody (1:40) 
for 1 hour. Tissue sections were washed with PBS twice 
(5 minutes each) and incubated with 1 to 100 diluted anti-rat 
HRP-labeled secondary antibody (Jackson ImmunoResearch 
Lab. Inc., West Grove, PA, USA) for 30 minutes. The 
images of the stained tissue sections were recorded using a 
microscope. The extensity of macrophage inﬁ  ltration was 
measured by the number of the positive cells per unit of area 
(0.01 square of millimeter). ANOVA was applied to test the 
statistical signiﬁ  cance of the difference among three groups 
(control, AngII-treated, and BaP-treated).Vascular Health and Risk Management 2008:4(5) 1097
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(Figure 1); Among them, one mouse in the group treated with 
AngII and ﬁ  ve mice in the group treated with both AngII 
and BaP exhibited AAA rupture and hematoma formation 
(Figure 2). These results indicate that BaP treatment 
increased not only AAA incidence but also the probability 
of AAA rupture in C57/B6J mice. Histological analysis of 
the aortic wall showed severe damage to the medial layer, 
breakage of elastic lamella, and aortic rupture (indicated by 
arrow) in mice treated with both AngII and BaP (Figure 1 A). 
The aortic wall at the location of rupture was signiﬁ  cantly 
thinner, compared to other parts of the wall. This damage, 
coupled to thinning of the wall (broken arrows) was also 
observed in other parts of the aorta (Figure 1A).
BaP causes damage to the arterial wall
To examine the individual effects of BaP or AngII on the 
aortic wall, we isolated aortas from control, BaP-treated, 
and AngII-treated mice. Tissue sections were taken from 
these aortas and stained with hematoxylin-eosin. The results 
of HE-staining are shown in Figure 3. BaP or AngII alone 
caused disarray and degradation of the elastic lamella. The 
medial layers of the aortas from AngII- and BaP-treated 
groups were considerably thinner than those in control 
mice. Although the medial layer of aortas from BaP-treated 
mice was severely damaged, the adventitia of the arteries 
was thicker than that of AngII-treated mice, an indication 
of adventitial remodeling. The appearance of the cells with 
rounded-shaped nuclei in the walls of the aortas isolated from 
AngII-treated and BaP-treated groups, suggests inﬁ  ltration of 
inﬂ  ammatory cells, which was conﬁ  rmed by the experimental 
result shown in Figure 4.
BaP-induced macrophage inﬁ  ltration into 
the arterial wall
Macrophages in the aortic wall were detected by immuno-
histochemistry staining with macrophage F4/80 antibody 
(GenTex, Inc. Cat# GTX26640). Macrophage inﬁ  ltration 
within the aortic wall was quantiﬁ  ed by counting the posi-
tively stained cells per area of 0.01 square millimeters in 
the aortic wall (Figure 4A). The results indicated that AngII 
or BaP treatment alone caused macrophage inﬁ  ltration into 
the aortic wall, with more intensive macrophage inﬁ  ltration 
shown in the aortas from BaP-treated mice (Figure 4B).
Discussion
The results of this study demonstrate that BaP, an important 
component of cigarette smoke, promotes the AAA formation 
and rupture in C57/B6J mice (Figure 1 and 2). Etiologically, 
Table 1 Circumferences (micrometers) of the aortas isolated from 
four experimental groups
Animal 
ID#
Control Ang BaP Ang/BaP
1 887.65 1151.532 1153.686 1499.692
2 1090.941 1489.89 896.985 1039.254
3 907.341 1291.079 1096.475 1521.023
4 1002.21 1510.573 995.901 1490.101
5 964.861 1065.989 1086.9 1097.25
6 872.238 1247.673 1201.32 1574.24
7 899.346 1005.46 1192.557 1203.209
8 990.461 1151.021 1095.535 1551.079
9 1012.021 1223.104 951.669 1507.532
10 897.452 1102.231 889.81 1312.361
11 968.241 995.94 1202.211 1185.018
12 860.498 1198.245 1055.892 1601.145
Note: The bolded numbers showed those circumferences of the aortas with AAA.
Abbreviations: AAA, abdominal aortic aneurysm; Ang, angiotensin; BaP, 
benzo(a)pyrene.
Experimental results
High incidence of AAA formation
and rupture in BaP/AngII-treated
C57/B6j mice
To answer the basic question of whether BaP has any impact 
on AAA formation, we treated four groups of C57/B6j mice 
(12 for each group) respectively with (1) medium chain 
triglyceride oil, a vehicle for BaP treatment, once a week, 
(2) BaP (10 mg/kg body weight, IP) once a week, (3) AngII 
(0.72 mg/kg body weight/day with osmotic pump), or (4) the 
combination of AngII and BaP (with the same doses). The 
subpressor dose of AngII had minimal effects on mouse blood 
pressure. At the end of 5 weeks of treatment, aortas from the 
arch to just above the iliac bifurcation were dissected and 
exposed under a dissecting microscope. Tissue sections of 
the suprarenal segments (a length of 1 cm long above left 
renal artery) from all aortas were obtained and stained with 
HE stain. The circumferences of the aortic rings from the 
four experimental groups were measured using NIH Image 
J, and shown in Table 1. The average circumference of the 
control mice was 946 ± 69 micrometers. The aortas with a cir-
cumference increased by 50% of the average circumference 
of the control mice, ie, more than 1417 micrometers, were 
considered as aneurysm formation.
The results showed that while AngII induced AAA in 2 
of 12 treated mice, the combination of BaP and AngII caused 
a signiﬁ  cantly higher incidence of AAA (7 of 12 animals) Vascular Health and Risk Management 2008:4(5) 1098
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AAA is considered a pathological consequence of the inter-
action between environmental factors and genetic traits. We 
have known for 30 years that cigarette smoking contributes 
to the formation and rupture of AAA (Alcorn et al 1996; 
Wilmink et al 1999; Rodin et al 2003). It is well established 
that the more and the longer a patient smoked, the greater 
the likelihood of AAA formation (Strachan 1991; Chang 
et al 1997; Blanchard et al 2000). There is no doubt that 
components of cigarette smoke contribute to AAA forma-
tion, but individual components have not yet been identiﬁ  ed. 
Among the many components of cigarette smoke, BaP causes 
unique biological effects consistent with the vascular pathol-
ogy seen in individuals who smoke (Ramos et al 2007). The 
pathological process of AAA was characterized by inﬁ  ltration 
and accumulation of macrophages in the arterial wall (Rubini 
et al 2001; Forester et al 2005), disruption of elastic lamella 
and deterioration of collagen networks (Thompson and Parks 
1996; Daugherty and Cassis 2002), and loss of VSMC in the 
media (Lopez-Candales et al 1997; Thompson et al 1997). 
Excessive expression of matrix MMPs has been observed 
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Figure 1 High incidence of AAA formation in C57/B6J mice treated with both AngII and BaP. Representative HE-stained tissue sections of suprarenal segments (1 cm above 
left renal artery) of the aortas from control and treated mice were shown (A). We measured the circumference of aortic rings from four experimental groups using the 
computer program of NIH Image J. AAA was deﬁ  ned as circumferences that were increased by more than 50% of the average circumference in the control group (946 ± 69 
micrometers). Seven mice from the group treated with both AngII/BaP and two from the AngII-treated group showed AAA formation with circumferences greater than 1417 
micrometer (B, each diamond represents a different mouse). Differences in the occurrence of AAA formation between the AngII-treated group and the group treated with 
both AngII and BaP was statistically signiﬁ  cant (P  0.05). Histology of the aortic wall showed severe damage to the medial layer, breakage of elastic lamella, hematoma, and 
aortic rupture (indicated by the arrow) in the mouse group treated with both AngII and BaP (A). The aortic wall at the location of rupture was signiﬁ  cantly thinner, compared 
to other parts of the aortic wall. A damaged and thinner aortic wall (broken arrows) was also observed in aortic rings harvested from mice treated with AngII and mice 
treated with both AngII and BaP.
Abbreviations: AAA, abdominal aortic aneurysm; AngII, angiotensin II; BaP, benzo(a)pyrene; HE, hematoxylin-eosin; NIH, National Institutes of Health.Vascular Health and Risk Management 2008:4(5) 1099
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in AAA tissue samples (Pyo et al 2000; Goodall et al 2001; 
Longo et al 2002), a change believed to be responsible 
for the degradation of elastin and collagen and the AAA 
formation (Holmes et al 1996; Longo et al 2005). In these 
pathological events, nuclear factor-κB plays a pivotal role 
by regulating macrophage migration and MMPs expression 
(Nakashima et al 2004; Parodi et al 2005). BaP induces 
inﬁ  ltration of macrophages (Curfs et al 2004), up-regulation 
of MMP activities (Haque et al 2005), and activation of 
nuclear factor-κB (Pei et al 2002; Weng et al 2004). BaP 
also suppresses collagen production of vascular endothelial 
cells and smooth muscle cells, that is similar to the effect of 
cigarette smoke extracts on the same cells (Raveendran et al 
2004). All these observations suggest that BaP may be one 
of the important components in cigarette smoke that promote 
the development of AAA. Nevertheless, to our knowledge, no 
direct evidence has yet been presented that BaP contributes to 
the development of AAA. Using the well established mouse 
model of AngII-induced AAA, we demonstrate here at the 
ﬁ  rst time the detrimental effect of BaP on the development 
of AAA in vivo. AngII has been known to cause AAA for-
mation in hyperlipidemic mice (apoE-deﬁ  cient) with high 
incidence rates (Daugherty et al 2000; Deng et al 2003; 
Martin-McNulty et al 2003). In C57/B6J mice, however, 
AngII-induced AAA formation is seen at considerably lower 
incidence rates (Deng et al 2003). The elevated incidence 
of AAA induced by combined treatment of C57/BB6J mice 
with AngII/BaP indicates a role for BaP in AAA formation. 
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Figure 2 High incidence of AAA rupture and hematoma formation in C57/B6J mice treated with both AngII and BaP. Representative photomicrographs of aortic segments 
from heart to kidney, harvested from control and treated mice were shown (A). Five mice from the group treated with both AngII and BaP and one in the AngII-treated 
group showed AAA rupture and hematoma formation (solid arrow). No arterial rupture or hematoma formation was observed in the control group or in the group treated 
with BaP alone. In mice treated with AngII/BaP, the yellowish stain surrounding tissues (indicated by broken arrow) was tightly attached to the adventitial layer of the aorta 
(A). The difference in occurrence of AAA rupture and hematoma formation between the AngII-treated group and the group treated with both AngII and BaP was statistically 
signiﬁ  cant (P  0.05) (B).
Abbreviations: AAA, abdominal aortic aneurysm; AngII, angiotensin II; BaP, benzo(a)pyrene.Vascular Health and Risk Management 2008:4(5) 1100
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Control (40x) AngII (40x) BaP (40x)
Figure 3 Damage of the arterial wall by AngII or BaP treatments. We show representative images of the aortic wall at the suprarenal segment of the aortas obtained from 
control, AngII-treated, and BaP-treated mice. Compared to control animals, the medial layer of aortas from AngII-treated mice and BaP-treated mice was shrunken; elastic 
lamella lost ﬁ  ne lines and instead degraded into loosely deﬁ  ned lines. These changes were particularly severe in aortas from BaP-treated mice, with fewer cells (VSMCs) seen 
in the medial layer. In adventitia, there were some cells with a rounded-shaped nucleus, resembling inﬂ  ammatory cells. Although the medial layer of the aortas from BaP-treated 
mice was severely damaged, the adventitia of the arteries was thicker.
Abbreviations: AngII, angiotensin II; BaP, benzo(a)pyrene; VSMCs, vascular smooth muscle cells.
Control (40x) AngII (40x) BaP(40x)
(A)
(B)
Control AngII BaP
M
i
c
r
o
p
h
a
g
e
s
 
(
p
e
r
 
0
.
0
1
 
s
q
.
 
m
m
) 60
50
40
30
20
10
0
Figure 4 Macrophage inﬁ  ltration into the aortic wall caused by AngII or BaP treatments. We present the images of immunohistochemical staining with macrophage F4/80 
antibody of aortic sections from control, AngII-treated and BaP-treated mice. Macrophage inﬁ  ltration within the aortic wall (brown staining) was quantiﬁ  ed by counting positively 
stained cells per area of 0.01 square millimeters (n = 6) (B). The results show that both AngII and BaP caused macrophage inﬁ  ltration into the aortic wall, but the response 
was more intense in BaP-treated mice.
Abbreviations: AAA, abdominal aortic aneurysm; AngII, angiotensin II; BaP, benzo(a)pyrene.
It is also important to note that BaP treatment increases the 
incidence of AAA rupture in mice (Figure 2). This might be, 
at least partly, account for the association between cigarette 
smoking and AAA rupture (Chang et al 1997).
To answer the question as to how BaP is involved in the 
development of AAA, we examined the individual effect 
of BaP or AngII on the biological structure of the aortic 
wall. Based on histological examination, we found that BaP 
alone caused macrophage inﬁ  ltration and structural damage 
to the aortic wall, but no aneurysm formation in C57/B6J 
mice. The medial layer of the aortas from both the AngII- 
or BaP-treated mice was considerably thinner compared to Vascular Health and Risk Management 2008:4(5) 1101
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aortas from control mice, apparently due to the degradation 
of elastin and collagen and loss of VSMCs (Figure 3). 
The appearance of round-shaped cells in the walls of the 
aortas isolated from AngII-treated and BaP-treated groups, 
suggests inﬁ  ltration of inﬂ  ammatory cells (Figure 3). This 
was conﬁ  rmed by immunohistochemistry staining with 
antibody against mouse macrophage (Figure 4). This is 
consistent with the observation made by Curfs and col-
leagues (2004) showing that using a comparable dose of 
BaP (5 mg/kg for 12 to 24 weeks, total dose in range of 
60 to 120 mg per kg body weight). BaP treatment led to 
macrophage inﬁ  ltration in the aortic wall of apoE-mutant 
mice (Curfs et al 2004). Although the medial layer of the 
aortas from BaP-treated mice was severely damaged, the 
adventitia of the arteries was thicker (Figure 3), a strong indi-
cation of adventitial remodeling. This explains why no AAA 
formation and rupture was observed in the BaP-treated 
group, even though the medial layer was severely dam-
aged. However, when in combination with the effects of 
AngII, the damage caused by BaP led to higher incidences 
of AAA compared to those of AngII-treated mice. These 
results indicate that there are synergistic interactions 
between BaP and AngII in the development of AAA in 
C57/B6J mice. Further studies are needed to understand 
the molecular mechanism of this synergistic effect. It will 
be interesting to determine the effects of BaP, AngII, and 
BaP/AngII on macrophage inﬁ  ltration and the degradation 
of elastic lamella and collagen, at different stages of AAA 
development, and to understand the temporal relationship 
between the BaP and AngII effects, as well as their interac-
tion during AAA development.
In summary, we report here that BaP causes disarray 
of elastic lamella, loss of VSMCs, shrinkage of the aortic 
wall, and inﬁ  ltration of inﬂ  ammatory cells, and increases 
the incidence of AAA formation and rupture in C57/B6J 
mice. BaP-induced damage to the aortic wall delineates 
the pathological mechanism by which this chemical agent 
enhances AAA development. These results shed light into 
the pathological mechanisms of AAA development.
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